Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

Sykes, M; Preffer, F; McAfee, S; Saidman, S L; Weymouth, D; Andrews, D M; Colby, C; Sackstein, R; Sachs, D H; Spitzer, T R

Sykes, M; Preffer, F; McAfee, S; Saidman, S L; Weymouth, D; Andrews, D M; Colby, C; Sackstein, R; Sachs, D H; Spitzer, T R.

Affiliation

Sykes M; Transplantation Biology Research Center, Surgical Service, Massachusetts General Hospital and Harvard Medical School, Boston 02129, USA. sykes@helix.mgh.harvard.edu

Lancet ; 353(9166): 1755-9, 1999 May 22.

Article in En | MEDLINE | ID: mdl-10347989

Subject(s)

Bone Marrow Transplantation; Lymphoma, Non-Hodgkin/therapy; Transplantation Conditioning/methods; Adult; Flow Cytometry; Graft Rejection; Graft vs Host Disease; Haplotypes; Histocompatibility Testing; Humans; Lymphoma, Non-Hodgkin/blood; Middle Aged; Transplantation, Homologous; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Lymphoma, Non-Hodgkin / Bone Marrow Transplantation / Transplantation Conditioning Limits: Adult / Humans / Middle aged Language: En Journal: Lancet Year: 1999 Document type: Article

Search on Google

XML

PubMed Links